Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Patel Jaikrishna — NephroGenex, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Patel Jaikrishna

Patel Jaikrishna

Chief Medical Officer at NephroGenex, Inc. · on record since Jul 28, 2015

Insider trading activity of Patel Jaikrishna

Transactions on record: 2; since Aug 7, 2015

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Nov 12, 2015

Figures computed from official regulatory filings — methodology.

Companies where Patel Jaikrishna has traded

NephroGenex, Inc.2 tx · Nov 12, 2015

Track record of Patel Jaikrishna

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Patel Jaikrishna

Co-insiders of Patel Jaikrishna

Care Capital III LLCNephroGenex, Inc.
Care Capital Investments III L.P.NephroGenex, Inc.
Care Capital Offshore Investments III LPNephroGenex, Inc.
Fox J. WesleyNephroGenex, Inc.
Hamill JohnNephroGenex, Inc.
Hannasch BrianNephroGenex, Inc.
KAIROUZ HABIBNephroGenex, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Legault PierreNephroGenex, Inc.

LESCHLY MARKNephroGenex, Inc.

Markham Richard JNephroGenex, Inc.

Mitchum James P.NephroGenex, Inc.

Peterson BobNephroGenex, Inc.

Rho Capital Partners LLCNephroGenex, Inc.

Rho Ventures V Affiliates, LLCNephroGenex, Inc.

Rho Ventures V, L.P.NephroGenex, Inc.

RMV V, L.L.C.NephroGenex, Inc.

RUCH JOSHUANephroGenex, Inc.

Seltzer Robert R.NephroGenex, Inc.

Steiner EugenNephroGenex, Inc.

Taglietti MarcoNephroGenex, Inc.

VOGELBAUM MARTINNephroGenex, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
NephroGenex, Inc.	Nov 12, 2015	Award	97,306	0.00 USD	$0	SEC
NephroGenex, Inc.	Aug 7, 2015	AwardD	54,347	0.00 USD	$0	SEC